Total Payments
$436.95
2024 Payments
$22.06
Companies
7
Transactions
24
Medicare Patients
3,576
Medicare Billing
$451,944
Payment Breakdown by Category
Food & Beverage$436.95 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $436.95 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $129.44 | 10 | $0 (2021) |
| Allergan, Inc. | $79.10 | 5 | $0 (2020) |
| PFIZER INC. | $56.60 | 2 | $0 (2019) |
| ABBVIE INC. | $51.98 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $50.61 | 1 | $0 (2022) |
| UCB, Inc. | $38.20 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $31.02 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.06 | 1 | UCB, Inc. ($22.06) |
| 2023 | $16.14 | 1 | UCB, Inc. ($16.14) |
| 2022 | $77.45 | 2 | Janssen Pharmaceuticals, Inc ($50.61) |
| 2021 | $160.72 | 11 | AstraZeneca Pharmaceuticals LP ($104.56) |
| 2020 | $40.18 | 3 | AstraZeneca Pharmaceuticals LP ($24.88) |
| 2019 | $46.54 | 2 | PFIZER INC. ($33.44) |
| 2018 | $35.43 | 2 | PFIZER INC. ($23.16) |
| 2017 | $38.43 | 2 | Allergan Inc. ($38.43) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Neurology | ||||||
| 11/13/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Neurology | ||||||
| 10/11/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: COVID-19 | ||||||
| 11/15/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: COVID-19 | ||||||
| 10/06/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/30/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/17/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/05/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/22/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/03/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/27/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/23/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 875 | 952 | $1.5M | $113,559 |
| 2022 | 4 | 761 | 815 | $1.6M | $102,568 |
| 2021 | 5 | 827 | 885 | $1.7M | $117,150 |
| 2020 | 6 | 1,113 | 1,185 | $1.7M | $118,668 |
Total Patients
3,576
Total Services
3,837
Medicare Billing
$451,944
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 598 | 659 | $1.2M | $86,820 | 7.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 180 | 194 | $245,261 | $16,904 | 6.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 52 | 53 | $110,958 | $8,270 | 7.5% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 30 | 31 | $24,265 | $1,488 | 6.1% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 15 | 15 | $795.00 | $77.10 | 9.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 544 | 593 | $1.2M | $82,181 | 6.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 121 | 125 | $180,521 | $10,987 | 6.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 37 | $94,003 | $6,409 | 6.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 59 | 60 | $51,717 | $2,991 | 5.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 553 | 601 | $1.2M | $87,699 | 7.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 134 | 140 | $198,385 | $12,308 | 6.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 65 | 65 | $164,927 | $12,166 | 7.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 63 | 67 | $57,446 | $3,647 | 6.3% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 12 | 12 | $19,933 | $1,330 | 6.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 623 | 677 | $1.3M | $90,140 | 7.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 71 | 71 | $174,269 | $12,371 | 7.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 121 | 123 | $159,434 | $11,074 | 6.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 67 | 69 | $49,303 | $3,209 | 6.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 220 | 234 | $23,060 | $1,534 | 6.7% |
| 12001 | Repair of wound (2.5 centimeters or less) of the scalp, neck, underarms, trunk, arms and/or legs | Facility | 2020 | 11 | 11 | $7,415 | $339.33 | 4.6% |
About Dr. William Murry, D.O
Dr. William Murry, D.O is a Emergency Medicine healthcare provider based in Lawton, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1447665260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Murry, D.O has received a total of $436.95 in payments from pharmaceutical and medical device companies, with $22.06 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($436.95).
As a Medicare-enrolled provider, Murry has provided services to 3,576 Medicare beneficiaries, totaling 3,837 services with total Medicare billing of $451,944. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Lawton, OK
- Active Since 07/01/2014
- Last Updated 06/29/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1447665260
Products in Payments
- LOKELMA (Drug) $129.44
- DALVANCE (Drug) $90.41
- ELIQUIS (Drug) $56.60
- XARELTO (Drug) $50.61
- Briviact (Drug) $38.20
- Veklury (Drug) $31.02
- TEFLARO (Drug) $28.40
- AVYCAZ (Drug) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Lawton
Dr. Jeffrey Golightly, M.d, M.D
Emergency Medicine — Payments: $2,236
Emergency Medicine $2,236
Jessica Meador, D.o, D.O
Emergency Medicine — Payments: $830.67
Emergency Medicine $830.67
Daniel Dorton
Emergency Medicine — Payments: $631.71
Emergency Medicine $631.71
Matthew Wood, D.o, D.O
Emergency Medicine — Payments: $529.56
Emergency Medicine $529.56
Jordan Price, Do, DO
Emergency Medicine — Payments: $428.66
Emergency Medicine $428.66
Dr. Alexander Swan, Do, DO
Emergency Medicine — Payments: $368.13
Emergency Medicine $368.13